Dionyssios Katsaros
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 150 publications
Rational adjustment of dose to reduce adverse reactions (RADAR) in patients with platinum-sensitive recurrent ovarian cancer: Results from the phase II NEWTON trial (ENGOT-ov49).
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 08, 2026
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial.
Journal: Obstetrical & gynecological survey
Published: October 30, 2025
A randomized, open-label phase II non-inferiority study of niraparib maintenance after 3 versus 6 cycles of platinum-based chemotherapy in patients with completely debulked advanced HRD-positive high-grade ovarian cancer in first-line therapy (N-PLUS/NOGGO-ov53/ENGOT-ov62).
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 14, 2025
CCDC6 Immunostaining in Conjunction with the Rad51 HRD Assay May Expand PARPi Treatment Eligibility in Patients with HGSOC.
Journal: Cancer research communications
Published: August 04, 2025
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial.
Journal: The Lancet. Oncology
Published: February 26, 2025
Mitochondrial tRNA fragment, mt-tRF-Tyr-GTA-001 (tRF-21-X3OJI8EWB), in breast cancer and its potential clinical implications.
Journal: Breast cancer research and treatment
Published: January 25, 2025
Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials.
Journal: The Lancet. Oncology
Published: November 27, 2023
Prediction of recurrence risk in endometrial cancer with multimodal deep learning.
Journal: Nature medicine
Published: November 27, 2023
Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 01, 2023
Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options.
Journal: Biomedicines
Published: April 27, 2023
Machine learning-based cluster analysis of immune cell subtypes and breast cancer survival.
Journal: Scientific reports
Published: December 16, 2022
Last Updated: 09/26/2026